Author of the publication

Atypical fibroxanthoma and pleomorphic dermal sarcoma – gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma

, , , , , , , , , , and . JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 21 (5): 482–491 (April 2023)
DOI: 10.1111/ddg.15006

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Blumert, Conny
add a person with the name Blumert, Conny
 

Other publications of authors with the same name

ProstaTrend-A multivariable prognostic RNA expression score for aggressive prostate cancer, , , , , , , , , and 18 other author(s). Eur. Urol., 78 (3): 452--459 (September 2020)A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activation, , , , , , , , , and . Genome Biology, (December 2023)Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer, , , , , , , , , and 8 other author(s). BMC Cancer, (June 2023)Atypical fibroxanthoma and pleomorphic dermal sarcoma – gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma, , , , , , , , , and 1 other author(s). JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 21 (5): 482–491 (April 2023)A reliable transcriptomic risk-score applicable to formalin-fixed paraffin-embedded biopsies improves outcome prediction in localized prostate cancer, , , , , , , , , and 9 other author(s). Molecular Medicine, (February 2024)Transcriptomic signatures reveal a shift towards an anti-inflammatory gene expression profile but also the induction of type I and type II interferon signaling networks through aryl hydrocarbon receptor activation in murine macrophages, , , , , , , , , and . Frontiers in Immunology, (May 2023)